Author:
Langer Lucy R.,Tevaarwerk Amye J.,Zon Robin,Osterman Travis
Abstract
Abstract
The COVID-19 pandemic has led to a massive surge in the use of telemedicine services in oncology. However, although telemedicine usage is not as high as it was early in the pandemic, it is not as low as it was before the pandemic, either, indicating that patients have a desire to receive care when, where, and how they want. Most oncology providers agree that telemedicine is beneficial and here to stay, but barriers hinder equitable delivery, such as racial/ethnic affiliations, older age, residing in a rural area, and lower socioeconomic status. The momentum created by the pandemic can serve to show the benefits of telemedicine and solidify its place in oncology care. However, addressing these disparities—and increasing widespread access to broadband and educating both patients and providers on how to use these technologies—is paramount.
Reference18 articles.
1. position statement telemedicine cross state licensure Accessed Available at https www asco org sites new www asco org files content files advocacy and policy documents ASCO Telemedicine Licensure pdf;ASCO,2022
2. PracticeNET Accessed Available at https practice asco org practice support practice benchmarking practicenet;ASCO,2022
3. Patient and physician attitudes toward telemedicine in cancer clinics following the COVID-19 pandemic;Wehrle;JCO Clin Cancer Inform,2021
4. Telehealth in oncology: ASCO standards and practice recommendations;Zon;JCO Oncol Pract,2021
5. Telehealth is a sustainable population health strategy to lower costs and increase quality of health care in rural Utah;Thota;JCO Oncol Pract,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献